Yüklüyor......
Infection risk in autoimmune hematological disorders with low‐dose rituximab treatment
BACKGROUND: Rituximab has been widely used in many autoimmune diseases. AIM: To evaluate the infection risk of rituximab in autoimmune hematological disorders. METHODS: Retrospectively studied and compared the clinical data of 89 patients in our hospital who used low‐dose rituximab (group R) or puls...
Kaydedildi:
| Yayımlandı: | J Clin Lab Anal |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7595891/ https://ncbi.nlm.nih.gov/pubmed/32794271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.23455 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|